True Path Pharmaceuticals Private Limited
About True Path Pharmaceuticals Private Limited
Data last updated:
True Path Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC149579. Its GSTIN is 23AAICT7596F1ZY (Madhya Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Kumar Sahu and Manisha Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1/309 3rd Floor Tower No 13 Silver City Sector 93, Noida, Uttar Pradesh, India – 201304.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.75 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹33,292 (net margin 7%) and EBITDA of ₹74,833 (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 1/309 3rd Floor Tower No 13 Silver City Sector 93, Noida, Uttar Pradesh, India – 201304
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of True Path Pharmaceuticals Private Limited
The main business activity of True Path Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of True Path Pharmaceuticals Private Limited FY 2025 filings available
True Path Pharmaceuticals Private Limited reported revenue of ₹4.75 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of True Path Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 59% over three years, including 2% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of True Path Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹74,833 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33,292 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of True Path Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 15.7% | •••• | •••• | •••• |
| Net Profit Margin | 7% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of True Path Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenvera Pharmaceuticals Private Limited | ₹4.8 Lakh (FY 2025) | •••• | •••• | •••• | Kalka, Haryana, India | |
| Bransen Pharmaceuticals Private Limited | ₹4.8 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Runkem Pharmaceuticals Private Limited | ₹4.79 Lakh (FY 2025) | •••• | •••• | 20.0% | •••• | Varanasi, Uttar Pradesh, India |
| Swift Well Pharmaceuticals Private Limited | ₹4.78 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Deeg, Rajasthan, India |
| Suffice Pharmaceuticals Private Limited | ₹4.77 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| True Path Pharmaceuticals Private Limited this company | ₹4.75 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Noida, Uttar Pradesh, India |
| Performance Pharmaceuticals Private Limited | ₹4.75 Lakh (FY 2019) | •••• | •••• | •••• | Delhi, India | |
| Jaitra Pharmaceuticals Private Limited | ₹4.74 Lakh (FY 2022) | •••• | •••• | 47.0% | •••• | Patna, Bihar, India |
| Bhavi Pharmaceuticals (OPC) Private Limited | ₹4.71 Lakh (FY 2021) | •••• | •••• | -20.0% | •••• | Jaipur, Rajasthan, India |
| Vintisk Pharmaceuticals Private Limited | ₹4.71 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Cleancare Pharmaceuticals Private Limited | ₹4.7 Lakh (FY 2021) | •••• | •••• | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below True Path Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Sahu | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Manisha Sahu | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
Ownership and Shareholding of True Path Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at True Path Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to True Path Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Amit Kumar Sahu was appointed as Director on 27 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for True Path Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by True Path Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of True Path Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICT7596F1ZY | Madhya Pradesh | Active | 10 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of True Path Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about True Path Pharmaceuticals Private Limited
True Path Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2021 (5+ years old) and is registered under CIN U24299UP2021PTC149579.
True Path Pharmaceuticals reported revenue of ₹4.75 Lakh for FY 2025 (up 2% YoY).
True Path Pharmaceuticals has 2 current directors:
- Amit Kumar Sahu - Director
- Manisha Sahu - Director
True Path Pharmaceuticals reported a net profit of ₹33,292 (net margin 7%) and EBITDA of ₹74,833 (EBITDA margin 15.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of True Path Pharmaceuticals is 59% over three years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of True Path Pharmaceuticals is 23AAICT7596F1ZY, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of True Path Pharmaceuticals is U24299UP2021PTC149579. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
True Path Pharmaceuticals was incorporated on 27 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of True Path Pharmaceuticals by revenue are Zenvera Pharmaceuticals Private Limited, Bransen Pharmaceuticals Private Limited, Runkem Pharmaceuticals Private Limited, Swift Well Pharmaceuticals Private Limited, Suffice Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Amit Kumar Sahu was appointed as Director on 27 Jul 2021. Manisha Sahu was appointed as Director on 27 Jul 2021.
The registered office of True Path Pharmaceuticals is at B – 1309 3rd Floor Tower No 13 Silver City Sector 93, Noida, Uttar Pradesh, India – 201304.